Literature DB >> 27223665

Evaluation of type II thyroplasty on phonatory physiology in an excised canine larynx model.

Erin E Devine1, Matthew R Hoffman1, Timothy M McCulloch1, Jack J Jiang1.   

Abstract

OBJECTIVES/HYPOTHESIS: Type II thyroplasty is an alternative treatment for spasmodic dysphonia, addressing hyperadduction by incising and lateralizing the thyroid cartilage. We quantified the effect of lateralization width on phonatory physiology using excised canine larynges.
METHODS: Normal closure, hyperadduction, and type II thyroplasty (lateralized up to 5 mm at 1-mm increments with hyperadducted arytenoids) were simulated in excised larynges (N = 7). Aerodynamic, acoustic, and videokymographic data were recorded at three subglottal pressures relative to phonation threshold pressure (PTP). One-way repeated measures analysis of variance assessed effect of condition on aerodynamic parameters. Random intercepts linear mixed effects models assessed effects of condition and subglottal pressure on acoustic and videokymographic parameters.
RESULTS: PTP differed across conditions (P < .001). Condition affected percent shimmer (P < .005) but not percent jitter. Both pressure (P < .03) and condition (P < .001) affected fundamental frequency. Pressure affected vibratory amplitude (P < .05) and intrafold phase difference (P < .05). Condition affected phase difference between the vocal folds (P < .001).
CONCLUSIONS: Hyperadduction increased PTP and worsened perturbation compared to normal, with near normal physiology restored with 1-mm lateralization. Further lateralization deteriorated voice quality and increased PTP. Acoustic and videokymographic results indicate that normal physiologic relationships between subglottal pressure and vibration are preserved at optimal lateralization width, but then degrade with further lateralization. The 1-mm optimal width observed here is due to the small canine larynx size. Future human trials would likely demonstrate a greater optimal width, with patient-specific value potentially determined based on larynx size and symptom severity. LEVEL OF EVIDENCE: NA Laryngoscope, 2016 127:396-404, 2017.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Type II thyroplasty; excised canine model; laryngeal framework surgery; laryngology; vocal folds

Mesh:

Year:  2016        PMID: 27223665      PMCID: PMC5123985          DOI: 10.1002/lary.26017

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  22 in total

1.  Type 2 thyroplasty for spasmodic dysphonia: fixation using a titanium bridge.

Authors:  Nobuhiko Isshiki; Ichiro Yamamoto; Suminori Fukagai
Journal:  Acta Otolaryngol       Date:  2004-04       Impact factor: 1.494

2.  Direct measurement of subglottic pressure and laryngeal resistance in normal subjects and in spasmodic dysphonia.

Authors:  R L Plant; A D Hillel
Journal:  J Voice       Date:  1998-09       Impact factor: 2.009

3.  Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.

Authors:  S Bielamowicz; C L Ludlow
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-02       Impact factor: 1.547

4.  Phonation threshold pressure measurements during phonation by airflow interruption.

Authors:  J Jiang; T O'Mara; D Conley; D Hanson
Journal:  Laryngoscope       Date:  1999-03       Impact factor: 3.325

5.  Surgical tips for type II thyroplasty for adductor spasmodic dysphonia: modified technique after reviewing unsatisfactory cases.

Authors:  Nobuhiko Isshiki; Tetsuji Sanuki
Journal:  Acta Otolaryngol       Date:  2010-02       Impact factor: 1.494

6.  Long-term voice handicap index after type II thyroplasty using titanium bridges for adductor spasmodic dysphonia.

Authors:  Tetsuji Sanuki; Eiji Yumoto; Narihiro Kodama; Ryosei Minoda; Yoshihiko Kumai
Journal:  Auris Nasus Larynx       Date:  2013-12-25       Impact factor: 1.863

7.  Overall evaluation of effectiveness of type II thyroplasty for adductor spasmodic dysphonia.

Authors:  Tetsuji Sanuki; Nobuhiko Isshiki
Journal:  Laryngoscope       Date:  2007-12       Impact factor: 3.325

8.  Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.

Authors:  R H Miller; G E Woodson; J Jankovic
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1987-06

Review 9.  Research priorities in spasmodic dysphonia.

Authors:  Christy L Ludlow; Charles H Adler; Gerald S Berke; Steven A Bielamowicz; Andrew Blitzer; Susan B Bressman; Mark Hallett; H A Jinnah; Uwe Juergens; Sandra B Martin; Joel S Perlmutter; Christine Sapienza; Andrew Singleton; Caroline M Tanner; Gayle E Woodson
Journal:  Otolaryngol Head Neck Surg       Date:  2008-10       Impact factor: 3.497

10.  Laryngeal muscle activity during speech breaks in adductor spasmodic dysphonia.

Authors:  E A Nash; C L Ludlow
Journal:  Laryngoscope       Date:  1996-04       Impact factor: 3.325

View more
  1 in total

Review 1.  Development of Excised Larynx.

Authors:  Rong Luo; Weijia Kong; Xin Wei; Jim Lamb; Jack J Jiang
Journal:  J Voice       Date:  2018-09-24       Impact factor: 2.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.